TY - JOUR
T1 - Structural and biological properties of erythropoietin in Xenopus laevis
AU - Nogawa-Kosaka, Nami
AU - Hirose, Takayuki
AU - Kosaka, Nobuyoshi
AU - Aizawa, Youichi
AU - Nagasawa, Kazumichi
AU - Uehara, Nobuaki
AU - Miyazaki, Hiroshi
AU - Komatsu, Norio
AU - Kato, Takashi
N1 - Funding Information:
The authors thank Dr. Shin Tochinai for J-strain X. laevis and Drs. Takahiro Ochiya, Kenji Ikebuchi, and Yusuke Yamamoto for constructive advice. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Tokyo, Japan) and from Waseda University (Tokyo, Japan) grants for special research projects. Part of this study was performed as a component of a Private University “High-Tech Research Center”project supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan). The nucleotide sequence reported in this article has been submitted to the DDBJ/EMBL/GenBank with accession number AB255452. Gene and protein symbols of Xenopus are suggested in Xenbase ( http://www.xenbase.org/gene/static/geneNomenclature.jsp ). However, for stating the comparative study of erythropoietin in this study, we named X. laevis erythropoietin gene as xlepo and erythropoietin protein as xlEPO instead of xlepo.
PY - 2010/5
Y1 - 2010/5
N2 - Objective: Erythropoietin (EPO) and its receptor (EPOR) are key regulators of red blood cell production in mammals and fish. We aimed to investigate the structural and functional conservation of the EPO-EPOR system in amphibian erythropoiesis, using Xenopus laevis as a model. Materials and Methods: X. laevis epo (xlepo) complementary DNA was identified by referring to the Xenopus tropicalis genome database. Biological activity of recombinant xlEPO expressed in COS-1 cells was evaluated using xlEPOR-expressing murine FDC/P2 cells and human EPO-dependent UT-7/EPO cells. Expression of xlepo messenger RNA in adult X. laevis tissues in the normal state and under the condition of phenylhydrazine-induced anemia was evaluated by real-time reverse transcription polymerase chain reaction. Results: In the encoded protein, the positions of four cysteine residues were conserved; however, xlEPO had only 38% identity with human EPO. N-glycosylation sites were absent. Recombinant xlEPO induced proliferation of cell lines expressing xlEPOR and UT-7/EPO, confirming biological activity and cross-species reactivity. Despite little primary amino acid sequence similarity, the evolutionary highly conserved sequence NFLRGK was identified in the EPOR-binding site 1 region as in the human EPO protein. Strong expression of xlepo messenger RNA was detected in the lung and liver, especially in fractionated hepatocytes. No marked increase in xlepo expression was seen in the lung and liver of phenylhydrazine-induced anemic X. laevis. Conclusion: We confirmed that xlEPO is the ligand to the previously reported xlEPOR in X. laevis. xlEPO shares structural and functional similarities and differences with mammalian counterparts, and regulation of xlepo expression and its influence on the erythropoietic system appears to be unique.
AB - Objective: Erythropoietin (EPO) and its receptor (EPOR) are key regulators of red blood cell production in mammals and fish. We aimed to investigate the structural and functional conservation of the EPO-EPOR system in amphibian erythropoiesis, using Xenopus laevis as a model. Materials and Methods: X. laevis epo (xlepo) complementary DNA was identified by referring to the Xenopus tropicalis genome database. Biological activity of recombinant xlEPO expressed in COS-1 cells was evaluated using xlEPOR-expressing murine FDC/P2 cells and human EPO-dependent UT-7/EPO cells. Expression of xlepo messenger RNA in adult X. laevis tissues in the normal state and under the condition of phenylhydrazine-induced anemia was evaluated by real-time reverse transcription polymerase chain reaction. Results: In the encoded protein, the positions of four cysteine residues were conserved; however, xlEPO had only 38% identity with human EPO. N-glycosylation sites were absent. Recombinant xlEPO induced proliferation of cell lines expressing xlEPOR and UT-7/EPO, confirming biological activity and cross-species reactivity. Despite little primary amino acid sequence similarity, the evolutionary highly conserved sequence NFLRGK was identified in the EPOR-binding site 1 region as in the human EPO protein. Strong expression of xlepo messenger RNA was detected in the lung and liver, especially in fractionated hepatocytes. No marked increase in xlepo expression was seen in the lung and liver of phenylhydrazine-induced anemic X. laevis. Conclusion: We confirmed that xlEPO is the ligand to the previously reported xlEPOR in X. laevis. xlEPO shares structural and functional similarities and differences with mammalian counterparts, and regulation of xlepo expression and its influence on the erythropoietic system appears to be unique.
UR - http://www.scopus.com/inward/record.url?scp=77951435638&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951435638&partnerID=8YFLogxK
U2 - 10.1016/j.exphem.2010.02.009
DO - 10.1016/j.exphem.2010.02.009
M3 - Article
C2 - 20193733
AN - SCOPUS:77951435638
SN - 0301-472X
VL - 38
SP - 363
EP - 372
JO - Experimental Hematology
JF - Experimental Hematology
IS - 5
ER -